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The immune response to oral bacteria and the subsequent
activation of inflammatory signaling is not only dependent on
genetic factors. The importance of so-called epigenetic
mechanisms presents additional regulatory pathways of
genes involved in maintaining chronic inflammation, includ-
ing gingivitis and periodontitis. The term epigenetics relates
to changes in gene expression that are not encoded in the
DNA sequence itself and include chemical alterations of
DNA and its associated proteins. These changes lead to
remodeling of the chromatin and subsequent activation or in-
activation of a gene. Epigenetic mechanisms have been found
to contribute to disease, including cancer and autoimmune or
inflammatory diseases. In this state-of-the art review, the au-
thors provide the latest findings on the involvement of epigenetic
modifications in the development of periodontal disease and
present emerging therapeutic strategies aimed at epigenetic
targets (epidrugs) associated with the disruption of tissue ho-
meostasis and the development of periodontitis. J Periodon-
tol 2015;86:556-568.
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P
eriodontitis is an infectious dis-
ease characterized by chronic in-
flammation in the gingival tissues
in response to bacteria colonizing the
tooth surface, ultimately leading to tissue
breakdown with loss of alveolar bone
and connective tissue.1 The epithelial cells
in the oral cavity are constantly being ex-
posed to high levels of various bacteria,
which leads to activation of multiple
signaling pathways that induce various
inflammatory response mechanisms.1
The host inflammatory response to bac-




The central dogma of gene expression is
that DNA is transcribed into messenger
RNA (mRNA), which serves as a tem-
plate for the protein synthesis.3 The
basic model for the transcriptional in-
duction in the immune response is that
external stimuli, such as bacterial prod-
ucts, start a signaling cascade within the
cells, activating the binding of transcrip-
tion factors to regulatory sequences of
the DNA, so-called promoters and en-
hancers. This assembles the transcription
initiation machinery and induces the ex-
pression of certain gene sets.4 At this
level, genetic changes such asmutations,
polymorphisms, or alterations in the DNA
sequence alter the binding sites for
transcription factors in the DNA regula-
tory region (promoter), thereby affecting
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not only the initiation speed but also the magnitude of
the gene expression. In addition, the form of the
protein, should these changes occur within the coding
regions of the gene (exons), results in changes in the
amino acid sequence of the protein.5
A recent study has revealed additional regulatory
layers superimposed on this basic model.4 Specific
functional programs able to be rapidly turned on and
off in response to external stimuli have been identi-
fied.4,6 These processes have been proposed as
a mechanism in creating a selectivity of the host
response to stimuli, and also to regulate the mag-
nitude of the inflammatory response to clear the
pathogens or drive chronic inflammation.7 In addi-
tion, this presents a potential mechanism of how
different bacterial species lead to activation of sig-
naling pathways, inducing inflammatory response
mechanisms.8
The layers of gene expression regulation of an
immune response include structures of the chromatin,
transcription factors, and posttranscriptional modifi-
cations, e.g., RNA splicing, mRNA polyadenylation,
and regulatory molecules, which include microRNA
(miRNA) and the recently identified long non-coding
RNAs (lncRNAs)9 (Fig. 1). The first two mechanisms
are: 1) modifications of the mRNA transcript and
2) regulation of the stability,
storage, and amount of mRNA
transcripts present in the cyto-
plasm. When DNA is transcribed
into mRNA, a process called
splicing removes the non-coding
sequences of mRNA (introns).
Bacterial products can alter the
splicing pattern, resulting in dif-
ferent isoforms of the protein
produced. After the transcription
and splicing, the mRNA tran-
script acquires a sequence of
adenosine bases at the terminal
end of the transcript called a poly
(A)tail. The length of this poly(A)
tail determines and contributes to
both mRNA stability and trans-
port to the cytoplasm. It also acts
as a mechanism for the cell to
store silenced mRNA within the
cytoplasm, which in response to
bacterial stimuli can be used to
rapidly induce gene expression
without having to start the DNA
transcription process in the nu-
cleus. This was also suggested
as a way to limit immune re-
sponse to avoid inducing chronic
inflammation.10
Not all RNA is protein coding.
miRNAs are small, evolution-
arily conserved ncRNAs that are
derived from longer transcripts
encoded within the genome.
They inhibit gene expression by
binding tomRNA by a sequence-
pairing homology to regulate
and fine-tune gene expression.
miRNA expression is altered in
response to bacterial products,
but inflammatory cytokines can
also influence the regulation of
Figure 1.
Epigenetic studies have identified multiple layers of regulatory factors and mechanisms that add to
the basic model for transcriptional induction in the immune response. Bacterial products and the
inflammatory process influence the transcriptional cascade at all levels.
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miRNA production.7 Recently, another class of
ncRNAs was discovered, the lncRNAs.7 Different
biologic functions have been attributed to lncRNAs.
A potential mechanism for their ability to regulate
gene expression is that they bind to chromatin
regulatory proteins, thereby controlling access or
inhibition of proteins binding to enhancer regions in
the DNA.3,11,12 One function of these RNAs in the
immune response has been suggested to involve the
regulation of the host response, including innate
immunity, since virus infection alters the expression
of lncRNAs.13 Interestingly, a recent report identified
a new ncRNA that is linked to epigenetic mecha-
nisms.14
Chronic inflammatory diseases, such as peri-
odontitis, have specific target tissues in which the
inflammation results in tissue breakdown.1 A specific
gene may possess different epigenetic patterns de-
pending on the cell type, resulting in local and sys-
temic expression of the gene. This indicates a local,
site-specific change in the immune response to ex-
ternal stimuli and/or the inflammatory response it-
self, which may differ among individuals and add to
the susceptibility to disease. This review focuses on
the epigenetic alterations of the chromatin and DNA,
how they can contribute to periodontal disease, and
the recent literature on their potential use as new
treatment targets.
EPIGENETICS
The term epigenetics relates to changes in gene
expression that are not encoded in the DNA se-
quence.15 Epigenetic modifications include chemical
alterations of DNA and associated proteins, leading
to remodeling of the chromatin and activation or
inactivation of a gene. These changes can contribute
Figure 2.
Schematic illustration of the influence of histone acetylation on gene transcription. Met = methylated; DNMTs = DNA methyltransferases; 5mC =
5-methylcytosine, K9HMT = Lysine 9 histone methyltransferase; AC = acetylation.
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to the development and maintenance of cancer and
autoimmune or inflammatory diseases, including peri-
odontitis. Interestingly, some epigenetic modifications
are reversible and can be induced and/or altered by
environmental factors, therefore presenting a link be-
tween the inherited genome and the environment.16,17
The two major epigenetic modifications are DNA
methylation and histone acetylation andmethylation.17
The building blocks of chromatin are the nucleo-
somes.17 One nucleosome consists of 146 base pair
(bp) DNA and a core histone complex, which includes
two copies each of histones H2A, H2B, H3, and H4
and the linker histone H1 that connects the nucleo-
somes, forming the primary chromatin structure, often
referred to as ‘‘beads-on-a-string.’’ Histones can be
acetylated or methylated at histone amino acid tails
that protrude from the nucleosome.18,19 Histone
acetylation is regulated by histone acetyltransferases
(HATs) and histone deacetylases (HDACs).20 Re-
moval of acetyl groups by HDACs leads to alterations
in the packing of DNA around histones and a sub-
sequent inactivation of genes (Fig. 2). In contrast,
hyperacetylation is associated with transcription-
ally active chromatin.20,21 Methylation occurs at
different lysine molecules on histones H3 and H4,
with H3 lysines K4 and K9 being most commonly
methylated.19 Although high levels of methylated K4
have been associated with transcriptionally active
regions, methylated K9 was found in silent chro-
matin regions.19 Importantly, a lysine can be mono-,
di-, or tri-methylated, further adding to the various
functions of methylated histones.19 However, recent
research in the area of histone methylation reveals
evidence for an even more complicated regulation
and function of histone methylation, with specific
methylation patterns in promoters, introns, and
exons resulting in a fine-tuning of gene expression.22
In the classic DNAmethylation model, the addition
of methyl groups to cytosine bases situated next to
a guanine base occurs at specific sites in the DNA
sequence, so-called CpG islands or CpG sites by the
de novo DNA methyltransferases (DNMTs) DNMT3a
and DNMT3b.15,23 This results in both methylated as
well as unmethylated CpG sites in the DNA strands.
The maintenance enzyme DNMT1 then remethylates
hemimethylated CpG sites.24 This modification alters
the configuration of the DNA and the binding of
transcription factors, resulting in changes in gene
expression. Transcriptionally active genes are as-
sociated with low levels of DNA methylation. How-
ever, in 2014, Jeltsch and Jurkowska24 presented
a modified version of this classic model based on
recent research findings. It was suggested that the
average DNA methylation (global DNA methylation)
level of DNA is inherited rather than the methylation
state of individual CpG sites (site-specific DNA
methylation). To add another level to the concept
of DNA methylation, it was discovered that 5-
methylcytosine (5mC) could be further oxidized into
5-hydroxymethylcytosine (5hmC) by the ten-eleven
translocation (TET) family of enzymes.25 The TET
enzymes can then convert 5hmC into unmethylated
cytosine, resulting in DNA hypomethylation.26 The
biologic function of 5hmC is not clear, but it has been
suggested to be an intermediate leading to deme-
thylation of 5mC and thereby re-expression of genes
silenced by DNA methylation (Fig. 3).27
Histonemodifications and DNAmethylation are not
separate events but are linked, and the resulting
combinations promote unique cellular responses.21,23
In addition, hypo-acetylated histones and hyper-
methylated CpGs in chronic inflammatory diseases
may result in persistent inflammation.20 In a recent
study, treatment of mice with a compound capable
of inducing a immune response (antigen stimula-
tion) resulted in a decrease of DNMT1 followed by an
increase in HDAC3.28
These changes may provide evidence of the in-
dividual differences in local expression of genes as-
sociated with inflammation. Specific factors have
been reported as risk factors for periodontitis, e.g.,
smoking, age, bacteria, and genetic polymorphisms.
Association between age and risk of developing
periodontitis has been reported.29,30 Comparison of
epigenetic patterns over time in twins at different
Figure 3.
Illustration of the different forms of DNA methylation and the proteins
regulating this process. 5caC = 5-carboxydeoxycytidine, 5fc =
5-formyldeoxycytidine, c = cytosine.
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ages showed large differences in gene
expression patterns, indicating that
epigenetic changes increase during life.
However, age itself contrasts with the
genetic changes seen in twins, since
age itself is a risk factor for epigenetic
changes.31 In addition, it has been
suggested that the epigenome of older
patients with periodontitis may differ
from that of younger patients.32 Epi-
genetic mechanisms may also explain
why some patients may not respond to
treatment and why some individuals
are more susceptible to periodontitis.32
Studies on epigenetic mechanisms in
relation to periodontitis33-47 are presented
in Table 1.
DNA Methylation and Periodontitis
In periodontitis, epigenetic modifica-
tions during inflammation occur locally
at the biofilm–gingival interface around
the teeth. It has been reported that the
epigenome differs between inflamed
periodontal sites and non-inflamed sites
in the same individual.33 In addition,
different methylation patterns asso-
ciated with pathways regulating cell
differentiation, apoptosis, lipopolysaccha-
ride (LPS)-mediated signaling, oncogen-
esis, and cell adhesion were found in
inflamed tissue from patients with peri-
odontitis compared with tissue from
healthy individuals.33
Several studies have investigated the
DNA methylation of inflammatory cyto-
kines in chronic periodontitis (CP) and
aggressive periodontitis (AgP).34-41
Analysis of the interleukin (IL)-8
promoter indicates a tissue-specific
pattern in DNA methylation.34 In
epithelial cells, the methylation fre-
quency of IL-8 was higher in controls
than in patients with periodontitis. No
difference was seen in gingival cells or
blood leukocytes.34 These findings are
in line with data that found that the
IL-8 promoter was hypomethylated in
oral epithelial cells from individuals
with generalized AgP compared with
healthy controls.35 The IL-6 promoter
was found to be partially methylated in
both healthy individuals and patients
with periodontitis,36 even though the
level of expression of IL-6 was higher
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increase in IL-6 serum level in patients with CP
compared with healthy individuals was associated
with hypomethylation of the -74 bp CpG site in
the IL-6 promoter. This suggests that DNA meth-
ylation of a single CpG site may influence cytokine
production and hence disease.37
The methylation level of interferon (IFN)-g has
been investigated in two studies.38,39 Viana et al.38
reported a similar methylation level of IFN-g and IL-10
in gingival biopsies from patients with CP compared
with biopsies from healthy controls. In contrast, Zhang
et al.39 reported a lower methylation level of CpG sites
in periodontitis biopsies compared with periodontally
healthy tissue biopsies. This was related to an increase
in IFN-g transcription. The increase in IFN-g in ex-
perimental gingivitis was found to be independent of
promoter methylation. Regarding the IL-10 gene,
no unmethylated samples were found in either peri-
odontitis or healthy tissues.38 Three CpG sites close to
the IL-10 promoter region around the -1,087 poly-
morphism were methylated in DNA from peripheral
blood cells and from gingival tissue. Treatment
of B cells with the DNA methylation inhibitor
5-aza-deoxycytidine resulted in an increase in IL-10
mRNA regardless of genotype for the -1,087 poly-
morphism.40 TwoCpG sites in the tumor necrosis factor
(TNF)-a promoter were reported to be hyper-
methylated in CP. In addition, transcription of
TNF-a was shown to be regulated by the meth-
ylation level, since treatment of ThP1 cells with 5-
aza-deoxycytidine increased TNF-a expression.41
In addition to methylation level of cytokines,
a number of other genes related to inflammation have
been analyzed in periodontitis.42-45 The DNA meth-
ylation pattern in the Toll-like receptor 2 (TLR2) and
TLR4 genes was evaluated in gingival tissue sam-
ples.42 The TLR4 gene promoter was unmethylated
in most samples in all groups,42 whereas the TLR2
promoter was both methylated and unmethylated
in most samples. A hypermethylation and a subsequent
low transcription of TLR2 in periodontitis tissues was
reported.43 Interestingly, a positive correlation was
found between TLR2 methylation and periodontal
probing depth. In a study on AgP, an overall deme-
thylation pattern of the suppressor of cytokine sig-
naling 1 (SOCS1) gene was found.44 In healthy
individuals, this demethylated level was higher, and
also total demethylated samples were found for this
group compared to periodontitis. A significant difference
was also reported regarding the methylation pattern for
the long interspersed element-1 (LINE-1) gene.44
The methylation status of the E-Cadherin and cy-
clooxygenase 2 (COX-2) genes was investigated in
patients with CP and patients with breast cancer.45
The results showed a hypermethylation of these two
genes in both patients with periodontitis and those
with cancer compared with healthy individuals. These
findings confirm the present view that chronic in-
flammation and cancer may have a similar epigenetic
pattern and that DNA methylation may be a link
between inflammation and cancer.48
A mechanism of how DNA methylation of a gene
promoter may influence gene expression was illus-
trated in a study by Zhang et al.47 in which hyper-
methylation of the prostaglandin-endoperoxide
synthase 2 (PTGS2) promoter in inflamed periodontal
tissue was associated with lower levels of PTGS2
transcription. Interestingly, a CpG site close to a nu-
clear factor (NF)-kB transcription factor-binding site
was highly methylated, suggesting that methylation
statusmay exclude binding of this transcription factor.
This is in line with other studies on methylation of
cytokine promoter regions in which the CpG sites
analyzed were in close proximity to binding sites for
transcription factors NF-kB and specificity protein 1
(Sp1).40,41 These two factors are known to be strong
regulators of gene expression of the immune re-
sponse. They are activated by bacteria binding to
TLRs and the subsequent activation of mitogen-
activated protein kinase (MAPK) pathways.49,50 The
influence of Sp1 and NF-kB on the chromatin struc-
ture was demonstrated byWidlak et al. in 1997,51 who
showed that the binding of Sp1 and NF-kB to adjacent
sites induced a repositioning of the nucleosomes
upstream and downstream of the factors, thereby
influencing gene transcription.51 It has been reported
that enzymes that cause methylation can be regulated
directly or indirectly by the extracellular milieu
through signal transduction pathways such as the
MAPK extracellular signal-regulated kinase (ERK)
kinase pathway.52
The inflammatory processes may also result in ab-
errant DNA methylation in tissues.53 This mechanism
has been suggested as a link between inflammation
and alterations in methylation level in cancers. In in-
flamed tissue, neutrophils and eosinophils produce
substances that further form halogenated cytosine
products.53 The DNMT1 enzyme cannot distinguish
between halogenated andmethylated DNA, resulting in
an increase in de novo methylation in cells of the in-
flamed tissue.53 In addition, antigen stimulation can
result in downregulation of DNMT1 and HDAC2, with
an increase in HDAC3, together with induction of Sp1
and NF-kB p65 binding to the HDAC3 promoter. The
downregulation of DNMT1 results in induction of ad-
hesion molecules and cellular interactions.28
The process of 5mC oxidation into 5hmC has been
well studied in cancer, but understanding of the role of
these markers in inflammation is limited. In a study
on the autoimmune disease systemic lupus eryth-
ematosus (SLE),54 the levels of TET1, TET2, and 5hmC
in cluster of differentiation 4–positive (CD4+) T cellswere
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compared to those from healthy individuals. A high level
of these markers in patients with SLE was found. It was
suggested that the DNA hydroxymethylation may be
contributing to the pathogenesis of SLE.54 Because SLE
and periodontitis share common features regarding the
immune response, it may also be that DNA hydrox-
ymethylation plays a role in periodontitis similar to that
in SLE.55 Bacterial influence of TET2 expression has
been previously shown, as Escherichia coli stimulation
of THP1 cells for 24 hours resulted in more than double
the amount of TET2 mRNA.56
Histone Modifications and Periodontitis
Few studies are available on histone modifications in
periodontitis.40,46 Maintaining histone acetylation of
genes related to osteoclastogenesis was found to be
important for preventing bone loss in experimental
periodontitis. Treatment with histone deacetylase
inhibitor (HDACi) resulted in improved bone levels.53
In a study from the authors’ laboratory,40 it was
demonstrated that different epigenetic modifications
of DNA and histones influence IL-10 gene expression.
The authors also found an association between LPS
stimulation and histone modifications. Furthermore,
these alterations differed among IL-10 genotypes for
the -1,087 G/A polymorphism in the IL-10 gene
promoter.40 Administration of HDACi trichostatin A
did not alter the IL-10 production; however, treatment
using HDACi butyrate and valproic acid resulted in an
increase in IL-10 gene expression.
Influence of Periodontal Pathogens on Chromatin
Modifications
An early report on the bacterial influence on DNA
methylation showed that bacterial infection with
Campylobacter rectus promoted DNA hyper-
methylation of the insulin-like growth factor 2
(IGF2) gene.57 Stimulation with the periodontal
pathogen Treponema denticola on periodontal liga-
ment cells showed a decrease in methylation of the
matrix metalloproteinase (MMP)-2 promoter.58
However, the authors could not confirm these find
ings using the more sensitive bisulfite DNA se-
quencing method.58 In addition, the MMP-2 promoter
was found to be hypomethylated regardless of the
presence of T. denticola. It was suggested that the
adherence and/or internalization of T. denticola may
contribute to regulation of matrix degradation and bone
resorption.58 Studies have shown that the culture super-
natant from the periodontal pathogen Porphyromonas
gingivalis contains high levels of butyric acid.59,60 This
culture supernatant was reported to inhibit HDACs,
resulting in increased histone acetylation.59,60
Periodontal pathogens can induce cell-specific
changes as shown in a study61 comparing the ex-
pression of epigenetic markers in gingival fibroblasts
and keratinocytes. P. gingivalis LPS stimulation re-
sulted in a decrease inmRNA transcription of DNMT1,
DNMT3, and histone demethylases Jumonji domain
containing 3 (JMJD3) in keratinocytes but not in
gingival fibroblasts. In contrast, RNA analysis from
gingival biopsies from periodontitis and healthy sites
showed no difference in gene expression for these
target genes.61 JMJD3 binds to genes and regulates
the H3K27me3 level and hence transcription activity.
It was suggested that a decrease in JMJD3 could
lead to changes in transcription levels of inflammatory
genes activated by LPS. Interestingly, JMJD3 is re-
gulated by NF-kB.61 Consistent with these findings
are the results presented by Yin and Chung,8 who
investigated the influence of P. gingivalis and Fuso-
bacterium nucleatum on epigenetic modifications in
gingival epithelial cells. P. gingivalis stimulation re-
sulted in a decrease in HDAC1, HDAC2, and DNMT1,
whereas no difference was found after stimulation
with F. nucleatum for those markers compared with
untreated cells. These results indicate that oral
bacterial infection is associated with changes in the
histone H3 lysine 4 (H3K4) methylation level, and
that the bacteria investigated induced different levels
of trimethylated H3K4. In addition, these bacteria
drove different epigenetic changes for the anti-
microbial proteins human b-defensin 2 and CC
chemokine ligand 20.
Specific cells within the oral mucosa may respond
differently to bacterial infection or to the periodontal
inflammatory processes.34 This results in differences
in the methylation pattern of a certain gene among
cell types. Analysis of epigenetic modifications from
gingival biopsies shows the combined results of all
cells present in the sample, making it difficult to
estimate the role of each cell type in the epigenetic
pattern at the site of inflammation.61 Barros and
Offenbacher used laser capture microdissection
(LCM) to analyze epithelial cells from the sulcular
epithelium.33 A large number of genes were analyzed,
but the gamma-amino-n-butyrate transaminase
(GATA) gene better illustrated differences in gene
expression between the gingival biopsies and LCM
tissue samples. The results from gingival samples
showed a 2.5-fold increase in GATA gene methyla-
tion, comparing healthy individuals versus patients
with periodontitis. This was confirmed using LCM,
with which a 1.2-fold increase was found.
However, not only do bacteria influence the
methylation level of a host’s genes, the bacterial DNA
can also differ in methylation level, which influences
their ability to induce the production of inflammatory
cytokines.62 The production of TNF-a in macrophages
was induced only when bacterial DNA from Ag-
gregatibacter actinomycetemcomitans, P. gingi-
valis, Peptostreptococcus micros, and E. coli was
unmethylated.62
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The studies on epigenetics and periodontitis de-
scribe how the immune response influences the
epigenetic pattern of genes. However, it should be
noted that epigenetic changes may also affect the
immune response itself, thereby providing a potential




Limited research has been done using HDAC or DNA
methylation inhibitors as treatments for periodontitis
or oral inflammation. In contrast, there are numerous
reports on the use of these epigenetic inhibitors in
cancer research. In a recent review,63 different areas
for use of epigenetic factors were identified to im-
prove individualized drug therapy, in which pharmaco-
epigenetic biomarkers can be used to predict drug
response. One example is the O6-methylguanine
DNA methyltransferase molecule that can be de-
tected in serum and saliva at levels corresponding to
that of the primary tumor. In this manner, it would be
possible to monitor epigenetic changes in a specific
tissue by using more easily accessible body fluids.
Epidrugs are defined as ‘‘drugs that inhibit or activate
disease-associated epigenetic proteins for amelio-
rating, curing, or preventing the disease.’’63 Indeed,
the present authors have found that administration of
epidrugs (HDACi) can prevent the accumulation of
head and neck cancer stem cells and increase the
sensitivity of tumor cells to chemotherapy.64,65 At
present, two DNMT inhibitors and two HDAC in-
hibitors have been approved by the U.S. Food and
Drug Administration. Although these developments
are exciting, the complexity of solid tumors are far
beyond current understanding, and the influence of
gene expressionmediated by histonemodifications is
in part impacted by the latest identification of several
mutations in histones and histone modifiers.66
Recently, HDACis have been found not only to
regulate histone acetylation but also to influence
DNA methylation.52 The HDACi suberoylanilide hy-
droxamic acid inhibits histone acetylation but also
regulates DNMT1 protein expression.52 Treatment
using another HDAC inhibitor, 1,179.4b (Classes I
and II HDACi), showed reduced alveolar bone loss
and less osteoclasts per square millimeter in mice
with P. gingivalis–induced periodontitis compared
with untreated mice.46 However, no influence was
found on the level of inflammation, which was sug-
gested to indicate a direct effect of this HDACi on
bone regeneration rather than an indirect effect by
targeting the inflammation.46 Moderate daily exer-
cise and diet were found to reduce P. gingivalis–
induced periodontitis in diet-induced obese mice by
restoring the level of histone 3 acetylation to normal,
as well as NF-kB recruitment to TNF-a and IL-10
promoter.67 It should be noted that P. gingivalis
produces butyric acid that in-
hibits HDACs and increases
histone acetylation, which was
shown to reactivate Epstein-Barr
virus (EBV) as well as human im-
munodeficiency virus 1, indicating
that periodontal disease may con-
tribute toEBV-relateddiseases.59,60
A group of epigenetic regula-
tory proteins are the bromodo-
main and extraterminal domain
(BET) proteins, which are able to
read acetylated histone tails and
recruit transcription complexes
to regulate gene transcription. In
a recent study, the BET inhibitor
JQ1 was found to inhibit both an
inflammatory response and alve-
olar bone loss in experimental
periodontitis. In vitro analysis of
the function of JQ1 revealed that
binding of the BET protein BRD4
to the NF-kB promoters was de-
creased, as was NF-kB phos-
phorylation, and treatment with
JQ1 also attenuated nuclear NF-
kB. Based on these findings, it
Figure 4.
Based on the studies presented in the present review, a potential hypothesis of the epigenetic events
occurring in a CP lesion. ROS = reactive oxygen species. AC = acetylase; SP1 = transcription factor.
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was suggested that JQ1 may be a potential treat-
ment model for periodontitis.68 Interestingly, aspirin
has been found to have a negative effect on allergic
inflammation by regulating DNMT1 expression. In
this model, aspirin was shown to prevent antigen
from influencing the expression of HAT Tip60, HDAC3,
and DNMT1.28
CONCLUSIONS
Recent studies have reported on the ability and im-
portance of environmental factors to induce changes
in epigenetic regulatory mechanisms of the immune
response (Fig. 4). Knowledge of the role of epige-
netics in development of periodontal diseases is still
limited, but the studies presented in this review
highlight that both DNA methylation and histone
modifications occur in the oral mucosa in response to
bacteria and the inflammatory processes. To better
understand the influence of environmental cues
during the development of periodontal disease, the
molecular events driven by epigenetic modifications
need to be identified. This information may also
provide some explanations as to why patients with
similar clinical characteristics respond differently to
treatment. Identifying epigenetic patterns associated
with the development of periodontitis may also im-
prove personalized approaches that can be used to
individualize treatment plans for patients with peri-
odontitis.
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